. Characterisation of angiogenesis in ve-ptp -/-EB. (a) EBs were immunostained with antibodies against CD31 (green) and NG2 (red). Nuclei were stained using Hoechst 33342 (blue). Scale bars; 20 µm. (b) Quantification of pericyte coverage in WT and ve-ptp -/sprouts, defined by ratio of NG2 to CD31 area. Data are shown as mean ± SD. n= 6 EBs/genotype. **; p < 0.01, paired t-test. (c-d) Transcript expression in endothelial cells isolated from 150 EBs each from WT and ve-ptp -/-EB 2D cultures at day 14 of differentiation. Expression levels of mRNAs were normalised to that of GAPDH. Mean ± S.D. Statistics based on two independent experiments are shown. expressing COS cells using an in vitro PTP assay. Blank (incubation of 32 P-labeled Src optimal peptide with PTP buffer without lysate) and empty vector (COS cells transfected with empty vector), were used as controls. Data shows mean ± SD. In parallel, expression of VE-PTP-V5 protein was confirmed by immunoblotting (inset). (b) PAE/VEGFR2 cells and HEK 293T cells transfected with Tie2-FLAG were stimulated with 50 ng/ml VEGF for 5 min, or 500 ng/ml Ang1 for 30 min, respectively. Phospho-VEGFR2 and phospho-Tie2 proteins were purified by immunoprecipitation using anti-VEGFR2 and anti-FLAG antibodies. The phosphoproteins were incubated In the presence of a VE-PTP catalytic domain fragment, followed by immunoblotting for phospho-tyrosine (pY), VEGFR2 and FLAG (Tie2). Figure S4 . Ang1 decreases pVEGFR2 levels at junctions. HUVECs were treated with 20 ng/ml VEGF with or without 200 ng/ml Ang1 for 5 or 60 min. Cells were immunostained with antibodies against pY1175 VEGFR2 (green), VEGFR2 (red) and ZO1 (blue). Scale bars; 20 µm. High-magnification insets show pVEGFR2 at cell-cell junctions. Scale bars; 10 µm. 
Supplementary Methods
In situ hybridisation Zebrafish total RNA was isolated from 24 hours postfertilisation (hpf) embryos and used for cloning the catalytic domain of zebrafish ptp-rb cDNA by realtime (rt) PCR. Two non-overlapping sequences, corresponding to nucleotides 3631-4649 (P1) and 4640-5551 (P2) in zebrafish ptp-rb were amplified by rtPCR and cloned into pBSSK. Antisense digoxygenin UTP labelled riboprobes were synthesised using T7 RNA polymerase. Whole-mount in situ hybridisation was performed according to Thisse et al. 61 . Embryos were cleared in benzyl alcohol/benzyl benzoate for imaging.
3' RACE Zebrafish total RNA was isolated from a 24-hour post fertilisation embryo. The catalytic domain of zebrafish ptp-rb was obtained by 3'RACE using GeneRacer TM Kit (Invitrogen). An approximately 1,000-basepair (bp) product was amplified by nested PCR using primers as follows; forward primer, 5'-GCTGGACTCTTCCTCATCGCCACCA-3'; reverse primer, 5' GCTGTCAACGATACGCTACGTAACG-3'; forward primer for nested PCR, 5'-TGGTGGGCTTAATCGTGCTGCTGGT-3'; reverse primer for nested PCR, 5'-CGCTACGTAACGGCATGACAGTG-3'. The PCR product was cloned into pCR ® 4Blunt-TOPO vector using Zero ® Blunt ® TOPO PCR Cloning Kit for Sequencing (Invitrogen). The sequence of the PCR product was determined.
Phosphatase activity COS (African green monkey fibroblast) cells were transfected with empty vector cDNA or VE-PTP-V5 expression vector cDNA, and lysed in 0.5% Triton X-100, 0.5% sodium deoxycholate, 150 mM NaCl, 1% trasylol, 1 mM benzamidine, 10 mM dithiothreitol (DTT) and 20 mM Tris HCl, pH 7.4. Lysates were incubated with anti-V5 antibody and precipitated using protein G-Sepharose. Precipitates on the beads were washed three times with lysis buffer and once with PTP buffer: 25 mM Imidazole, pH 7.4, 10 mM DTT and 0.1 mg/ml BSA, suspended in 100 ml protein tyrosine phosphatase (PTP) buffer and split into equal aliquots. Samples were incubated for 7 min at 30°C with substrate solution: 32 P-labeled Src optimal peptide (AEEEIYGEFEAKKKK) in PTP buffer. The phosphatase reaction was stopped using charcoal solution: 0.9 M HCl, 90 mM sodium pyrophosphate, 2 mM NaH 2 PO 4 and 4% Norit A (MP Biomedicals). The radioactivity of Src peptide-derived 32 P-phosphate in the supernatants without the beads and charcoal was measured in a beta counter.
Alternatively, PAE/VEGFR2 cells or HEK392T cells expressing Tie2-FLAG were treated with VEGF or Ang1, immunoprecipitated to collect VEGFR2 or Tie2 and precipitates incubated with a purified intracellular domain fragment of PTPRB (PTPRβ; Millipore) as specified by the manufacturer. The immunoprecipitates were analysed by SDS-PAGE and immunoblotting with anti-phospho-tyrosine antibodies.
Primers for transcript analysis
The following primers were used: Mouse (m) ve-ptp forward primer, 5'-TGAGGCATGGAGCCCTAACGGC-3', mve-ptp reverse primer, 5'-ACCACATGGGCCCCGAGGTATC-3', mgapdh forward primer, 5'-GGAGCGAGACCCCACTAACAT-3', mgapdh reverse primer, 5'-ACATACTCAGCACCGGCCTC-3'.
The following pre-designed primers from Applied Biosystems were used: mgapdh; part number 4352932E, vegfr2; Mm01222421_m1, delta-like 4 (dll4); Mm00444619_m1, notch1; Mm00435249_m1, mve-cadherin; Mm00486938_m1.
Immunofluorescent staining Confluent human umbilical vein endothelial cells (HUVECs) were fixed in 4% para-formaldehyde (PFA) for 10 min, permeabilised in 0.2% Triton-X100 in PBS for 5 min and blocked in 3% BSA/ PBS for 30 min, followed by immunofluorescent staining using antibodies against pY1175 VEGFR2 (Cell Signaling), VEGFR2 (R&D) and ZO1 (BD Biosciences). Confocal images were rendered on a Zeiss LSM700 microscope.
Three-dimensional (3D) image construction and quantification Immunofluorescent staining of embryoid bodies (EBs) cultured in 3D collagen gel 22 , using antibodies against VE-cadherin and ZO1 was followed by confocal analyses (LSM700, Carl Zeiss) and construction of 3D images by Imaris (Bitplane). Quantification of VE-cadherin accumulation at cell-cell junctions was performed using Imaris. Briefly, based on 3D images, the area of VE-cadherin at cell-cell junctions (mm 3 ), defined by co-localisation with ZO1-positive area, in 100 µm sprout lengths was determined.
Immunoprecipitation and immunoblotting Immunoprecipitation of HUVEC lysates using antibodies against VE-cadherin and VEGFR2 was performed, followed by immunoblotting using antibodies against pY658 VE-cadherin, VE-cadherin, pY1175 VEGFR2 and VEGFR2 as described previously 62 .
Alignment of VE-PTP catalytic domains from different species Alignment of the catalytic domains in VE-PTP proteins from human, mouse and zebrafish was done using the BLST function (NCBI).
Verification of zebrafish veptp MO
The following two sets of primers were used to verify the effect of zebrafish (z) veptp MO by two-step PCR: First forward primer, 1, 5'-TTT GGT ACC TGG TGT CCA TCA AAG TGC A-3': first reverse primer, 1, 5'-CTG GGA CTC CAT GGG CTG GCC ACA CCG T-3'.
